Abstract
We assessed the effect of referral bias on patients with ALS treated at our medical center. A total of 132 subjects were treated by our center over the past 3 years. The referral population had a median survival of 29 months compared to 18 months for the local population (p = 0.007). Referral bias should be addressed when assessing the efficacy of self-selected therapies in the setting of a tertiary ALS clinic.
Original language | English (US) |
---|---|
Pages (from-to) | 600-602 |
Number of pages | 3 |
Journal | Neurology |
Volume | 68 |
Issue number | 8 |
DOIs | |
State | Published - Feb 2007 |
ASJC Scopus subject areas
- Clinical Neurology